Antonio Cannata MD , Mehrdad A. Mizani PhD , Daniel I. Bromage PhD , Susan E. Piper MD , Suzanna M.C. Hardman PhD , Cathie Sudlow PhD , Mark de Belder MD , Paul A. Scott MD , John Deanfield FRCP , Roy S. Gardner MD , Andrew L. Clark MD , John G.F. Cleland MD , Theresa A. McDonagh MD , CVD-COVID-UK/COVID-IMPACT Consortium
{"title":"Heart Failure Specialist Care and Long-Term Outcomes for Patients Admitted With Acute Heart Failure","authors":"Antonio Cannata MD , Mehrdad A. Mizani PhD , Daniel I. Bromage PhD , Susan E. Piper MD , Suzanna M.C. Hardman PhD , Cathie Sudlow PhD , Mark de Belder MD , Paul A. Scott MD , John Deanfield FRCP , Roy S. Gardner MD , Andrew L. Clark MD , John G.F. Cleland MD , Theresa A. McDonagh MD , CVD-COVID-UK/COVID-IMPACT Consortium","doi":"10.1016/j.jchf.2024.06.013","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>For patients with acute heart failure (HF), specialist HF care during admission improves diagnosis and treatments.</div></div><div><h3>Objectives</h3><div>The authors aimed to investigate the association of HF specialist care with in-hospital and longer term prognosis.</div></div><div><h3>Methods</h3><div>The authors used data from the National Heart Failure Audit from January 1, 2018, to December 31, 2022, linked to electronic records for hospitalization and deaths. All-cause mortality was the primary outcome measure and in-hospital mortality the secondary outcome measure.</div></div><div><h3>Results</h3><div>Data for 227,170 patients admitted to hospital with HF (median age: 81 years; IQR: 72-88 years), were analyzed. Approximately 80% of acute HF admissions received support from HF specialists. Thirty-nine percent of patients (n = 70,720) were seen by a multidisciplinary team (HF physicians and heart failure specialist nurses [HFSNs]), 22% (n = 40,330) were seen by HFSNs alone, and the remaining 39% (n = 71,700) were seen exclusively by specialist HF physicians. At discharge, more patients who received HF specialist care were prescribed medical therapy for HF and had specialized follow-up. Conversely, diuretic agents were prescribed to fewer patients. HF specialist care was independently associated with a higher rate of prescribing HF therapies at discharge and a lower likelihood of receiving diuretic therapy (OR: 0.90 [95% CI: 0.86-0.95]; <em>P <</em> 0.001). HF specialist care was associated with better long-term survival (HR: 0.89 [95% CI: 0.87-0.90]; <em>P <</em> 0.001) and lower in-hospital mortality (OR: 0.92 [95% CI: 0.0.88-0.97]; <em>P <</em> 0.001).</div></div><div><h3>Conclusions</h3><div>Receiving HF specialist care during admission for HF is associated with a higher rate of implementation of medical therapy, fewer discharges on diuretic therapy, and lower in-hospital and long-term mortality across the left ventricular ejection fraction spectrum, especially for patients with heart failure with reduced ejection fraction.</div></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 3","pages":"Pages 402-413"},"PeriodicalIF":10.3000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213177924005134","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
For patients with acute heart failure (HF), specialist HF care during admission improves diagnosis and treatments.
Objectives
The authors aimed to investigate the association of HF specialist care with in-hospital and longer term prognosis.
Methods
The authors used data from the National Heart Failure Audit from January 1, 2018, to December 31, 2022, linked to electronic records for hospitalization and deaths. All-cause mortality was the primary outcome measure and in-hospital mortality the secondary outcome measure.
Results
Data for 227,170 patients admitted to hospital with HF (median age: 81 years; IQR: 72-88 years), were analyzed. Approximately 80% of acute HF admissions received support from HF specialists. Thirty-nine percent of patients (n = 70,720) were seen by a multidisciplinary team (HF physicians and heart failure specialist nurses [HFSNs]), 22% (n = 40,330) were seen by HFSNs alone, and the remaining 39% (n = 71,700) were seen exclusively by specialist HF physicians. At discharge, more patients who received HF specialist care were prescribed medical therapy for HF and had specialized follow-up. Conversely, diuretic agents were prescribed to fewer patients. HF specialist care was independently associated with a higher rate of prescribing HF therapies at discharge and a lower likelihood of receiving diuretic therapy (OR: 0.90 [95% CI: 0.86-0.95]; P < 0.001). HF specialist care was associated with better long-term survival (HR: 0.89 [95% CI: 0.87-0.90]; P < 0.001) and lower in-hospital mortality (OR: 0.92 [95% CI: 0.0.88-0.97]; P < 0.001).
Conclusions
Receiving HF specialist care during admission for HF is associated with a higher rate of implementation of medical therapy, fewer discharges on diuretic therapy, and lower in-hospital and long-term mortality across the left ventricular ejection fraction spectrum, especially for patients with heart failure with reduced ejection fraction.
期刊介绍:
JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.